Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.25    0.00 (0.00%)
Bid:
2.19
Ask:
2.23
Spread: 0.04 (1.826%)
Market Cap: $727.37m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Holding(s) in Company

28 May 2024 07:00

RNS Number : 9370P
RTW Biotech Opportunities Ltd
28 May 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GG00BKTRRM22

Issuer Name

RTW BIOTECH OPPORTUNITIES LTD

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

Other

Comments

As a result of RTW Biotech Opportunities Ltd.'s ("RTW") recent cancellation of 48,322,863 of its shares, Bluestem's interest in RTW has increased to 10.14%, which triggers the notification threshold.

3. Details of person subject to the notification obligation

Name

Bluestem Asset Management, LLC

City of registered office (if applicable)

Charlottesville

Country of registered office (if applicable)

United States

Name

City of registered office

Country of registered office

Bluestem Partners, LP

Wilmington Delaware

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

24-May-2024

6. Date on which Issuer notified

24-May-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.140000

0.000000

10.140000

34,093,156

Position of previous notification (if applicable)

8.740000

0.000000

8.740000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GG00BKTRRM22

34,093,156

10.140000

Sub Total 8.A

34,093,156

10.140000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Michael D. Bills

Bluestem Asset Management LLC

10.140000

0.000000

10.140000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Michael D. Bills has sole authority for Bluestem Asset Management, LLC, as its Managing Member. Bluestem Asset Management, LLC is the General Partner of the Shareholder, Bluestem Partners, LP, and is authorized to act for Bluestem Partners, LP on all matters.

 

The last notification was submitted to the FCA and the issuer on February 16, 2024. Bluestem's interest in RTW at that time was 8.74%.

12. Date of Completion

24-May-2024

13. Place Of Completion

Charlottesville, VA USA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFZGZKRKZGDZG
Date   Source Headline
12th Jun 20267:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20264:45 pmRNSResult of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 20267:00 amRNSNotice of AGM
14th May 20267:00 amRNSMonthly Valuation Update and Factsheet
12th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSAdditional investment in Windward Bio
6th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20263:00 pmRNSAnnual Financial Report
24th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSKailera completes $625 million IPO
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSReplacement RNS: Monthly Valuation Update
15th Apr 20267:01 amRNSObsidian Therapeutics reverse merger with Galera
15th Apr 20267:00 amRNSMonthly Valuation Update and Factsheet
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSApellis and Centessa to be acquired
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAmani closes $25 million Series A financing
30th Mar 20267:01 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Financial Report
27th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.